Sales Portal
For Patients For Surgeons

Board of Directors

 

James T. Treace, Chairman of the Board

James T. Treace has served as the chairman of our board of directors since June 2014. Mr. Treace has served as the Founder and President of J&A Group, LLC, a privately funded medical device investment and consulting company, since October 2000. Before that, from November 1999 to October 2000, Mr. Treace served as President of Medtronic Xomed, a subsidiary of Medtronic plc (NYSE: MDT). From April 1996 to November 1999, Mr. Treace served as Chief Executive Officer, President and Chairman of the board of directors of Xomed Surgical Products, Inc. (NASDAQ: XOMD), until it was acquired by Medtronic plc. From July 1993 to April 1996, Mr. Treace co-founded and served as the Chief Executive Officer and Chairman of the Board at TreBay Medical Corp., an orthopaedic and microsurgical device company. From September 1981 to July 1990, he served as President and Chief Executive Officer of Concept, Inc. (NASDAQ: CCPT), now known as Conmed Linvatec (NYSE: CNMD) and from June 1966 to September 1981 as Executive Vice President of Richards Medical, now known as Smith & Nephew (NYSE: SNN). Mr. Treace previously served as Chairman of the Boards of Kyphon, Inc. (NASDAQ: KYPH), now part of Medtronic plc, Wright Medical, acquired by Stryker Corporation (NYSE: SYK) in November 2020, American Medical Systems, Inc. (NASDAQ: AMMD), now part of Endo Pharmaceuticals (NASDAQ: ENDP), and Keystone Dental, Inc., a privately-held dental implant company.

John K. Bakewell, Board Member

John K. Bakewell has served as a member of our board of directors since November 2020.  He has served in senior executive roles for nearly three decades, building and executing business strategies for growth companies across the medical device, specialty pharmaceuticals, diagnostics and healthcare provider sectors, while also serving on public- and private-company boards. His professional experience includes serving for nine years as Executive Vice President and Chief Financial Officer of Wright Medical Group, Inc., acquired by Stryker Corporation (NYSE: SYK) in November 2020, from its private equity-backed reorganization through the company’s initial public offering, multiple years of industry-leading growth and creation of its industry-leading lower extremities franchise. Additionally, Mr. Bakewell served in Chief Financial Officer roles at Cyberonics Inc., now part of LivaNova (NASDAQ: LIVN); Lantheus Holdings, Inc. (NASDAQ: LNTH); Exact Sciences Corporation (NASDAQ: EXAS), a molecular diagnostics company; and RegionalCare Hospital Partners, Inc., now part of LifePoint Health. Mr. Bakewell currently serves on the board of directors of Neuronetics, Inc. (NASDAQ: STIM) and Xtant Medical Holdings, Inc. (XTNT), and has previously served on several other public and private company boards, including Entellus Medical, Inc., now part of Stryker Corporation (NYSE: SYK); ev3, Inc., now part of Medtronic plc. (NYSE: MDT); Corindus Vascular Robotics, Inc., now a Siemens Healthineers company; and Keystone Dental, Inc. He began his career as a Certified Public Accountant with seven years, collectively, at KPMG and Ernst & Young. He holds a BA in Accounting from the University of Northern Iowa.

F. Barry Bays, Board Member

F. Barry Bays has served as a member of our board of directors since June 2014. From January 2000 to June 2008, he served in various senior leadership roles with Wright Medical Group, Inc., acquired by Stryker Corporation (NYSE: SYK) in November 2020, including as Executive Chairman from June 2004 to October 2005, and again from April 2006 to June 2008, and as President and Chief Executive Officer from January 2000 to June 2004, and again from October 2005 to April 2006. From 1996 to 2000, Mr. Bays served as the Chief Operating Officer of Xomed Surgical Products, Inc., acquired by Medtronic plc (NYSE: MDT) in 1999. Mr. Bays has also served in leadership roles at TreBay Medical Corp., Concept, Inc., now known as Conmed Linvatec (NYSE: CNMD), and Richards Medical, now known as Smith & Nephew (NYSE: SNN). Mr. Bays holds a B.S. in Mechanical Engineering from Christian Brothers University.

Lawrence W. Hamilton, Board Member

Lawrence W. Hamilton, MPA, Ed.S., SPHR, CCP, BCC, has served as a member of our board of directors since November 2020. Mr. Hamilton has served as an Executive Coach and Adjunct Faculty with the Center for Creative Leadership at Eckerd College since September 2008. He also manages a private executive coaching and HR consulting practice, Hamilton Consulting. From July 1993 to July 2006, Mr. Hamilton served in various roles at Tech Data Corporation, a technology distributor with over 11,000 associates worldwide, most recently as Senior Vice President, Human Resources.  He also served as Vice President of Human Resources and Administration at Linvatec and in a variety of human resource management positions at Bristol-Myers Squibb Company (NYSE: BMY). Mr. Hamilton has also previously served as a member of the board of directors of Wright Medical Group, Inc., acquired by Stryker Corporation (NYSE: SYK) in November 2020, and HomeBanc Mortgage (NYSE: HBMC). Mr. Hamilton holds a BA in Political Sciences from Fisk University, an MPA (Labor) Policy from the University of Alabama and an Ed.S. in Human Resources Development from George Washington University. Mr. Hamilton is a certified Senior Professional in Human Resources and holds the Certified Compensation Professional designation from the American Compensation Association.

Mr. Hamilton was also appointed to the board of the National Association of State Boards of Accountancy (NASBA) Center for the Public Trust (CPT), the University of South Florida, St. Petersburg Campus Board of Directors, and the Carter-Edison Advisory Board.

Richard W. Mott, Board Member

Richard W. Mott has served as a member of our board of directors since March 2015. Mr. Mott has served as the Chairman and Interim CEO of Endologix, LLC, a medical device company, since October 2020.  He is also currently the principal of Walkabout Consulting, LLC, a management consulting and private equity firm, as well as a director and owner of VFD Technologies, a private equity firm that invests in high performance materials and medical device manufacturing businesses. From September 2002 to November 2007, Mr. Mott has also served as President, CEO and Director of Kyphon Inc., a NASDAQ-listed global medical device company through its acquisition by Medtronic plc (NYSE: MDT). Before that, Mr. Mott held various management positions at Wilson Greatbatch Technologies, Inc. and Bristol-Myers Squibb Co. (NYSE: BMY). From May 2008 to December 2017, Mr. Mott served as a member of the board of directors of Silk Road Medical, Inc. (NASDAQ: SILK), a medical device company. Mr. Mott currently serves on the board of various private companies, including Conventus Orthopaedics Inc., a developer of fracture fixation technology. He is the previous recipient of the Ernst & Young Entrepreneur of the Year Award, the Frost & Sullivan Technology Leadership of the Year Award, and the Phoenix Lifetime Achievement Award. He holds a B.S. in Ceramic Engineering from Alfred University, and is a Graduate of Harvard University’s Advanced Management Program.

Thomas E. Timbie, Board Member

Thomas E. Timbie has served as a member of our board of directors since June 2014 and served as our Chief Financial Officer from July 2014 to October 2015. Mr. Timbie is the President of Timbie & Company, LLC, a financial and management consulting firm he founded in 2000. Mr. Timbie has over 30 years of financial experience primarily in the medical device market. During 2005, as the interim Chief Financial Officer of ev3 Inc., acquired by Covidien in 2010 and now part of Medtronic plc. (NYSE: MDT), Mr. Timbie helped lead ev3 through their initial public offering. He was also the Chief Financial Officer of Xomed Surgical Products, Inc., including during its initial public offering in 1996, and continuing in that role until Xomed was acquired by Medtronic plc (NYSE: MDT) in 1999. Prior to Xomed, Mr. Timbie was the Chief Financial Officer of TreBay Medical Corp., a private orthopaedic and microsurgical device company, and the Director of Accounting at Concept Inc., a leader in the arthroscopy device market, now known as Conmed Linvatec (NYSE: CNMD). Timbie has also previously served as a member of the board of directors of Wright Medical Group, Inc., acquired by Stryker Corporation (NYSE: SYK) in November 2020; ev3 Inc., until its acquisition by Covidien (part of Medtronic plc. (NYSE: MDT)); and American Medical Systems, Inc., now part of Endo Pharmaceuticals (NASDAQ: ENDP). Mr. Timbie holds a B.S. in Accounting from University of Florida, an M.B.A. from Stetson University and is a certified public accountant (current status inactive). Mr. Timbie has also served as a board member and audit committee chairman of several public and private medical device companies including Wright Medical, Inc. acquired by Stryker Corporation (NYSE: SYK) in November 2020; ev3 Inc., acquired by Covidien in 2010 and now part of Medtronic plc. (NYSE: MDT); Acclarent, Inc., acquired by Johnson & Johnson (NYSE: JNJ) in 2010; and American Medical Systems, Inc. acquired by Endo Pharmaceuticals (NASDAQ: ENDP) in 2011. Mr. Timbie is also a former board member and audit committee chairman of two health care services companies, LaVie Care Centers and RegionalCare Hospital Partners.

John R. Treace, Board Member

John R. Treace has served as a member of our board of directors since June 2014. He is the President and Founder of JR Treace & Associates, a sales and marketing consulting firm in Jacksonville, Florida, since September 2011. Before that, Mr. Treace served in various senior management roles at Wright Medical Group, Inc., acquired by Stryker Corporation (NYSE: SYK) in November 2020, including as Vice President, US Sales from September 2000 to May 2004, Executive Vice President of North American Sales from October 2005 to March 2007 and as Special Assistant to the President from April through December 2007. Mr. Treace held various management positions at Medtronic Xomed, a subsidiary of Medtronic plc (NYSE: MDT), TreBay Medical Corp., and Richards Medical, now known as Smith & Nephew (NYSE: SNN). Mr. Treace holds a B.S. in Psychology from University of Memphis. He is the author of Amazon’s top seller, Nuts & Bolts of Sales Management, How to Build a High Velocity Sales Organization, and was the author of monthly column for Inc. Magazine and a member of the National Speaker’s Association.

John T. Treace, CEO, Founder and Board Member

John T. Treace has over 25 years of experience in medical device marketing, sales, and general management. Mr. Treace founded our company in January 2014 and has served as our Chief Executive Officer and a member of our board of directors since our inception. Mr. Treace is the former Senior Vice President of US Sales and Global Marketing for Wright Medical Group, Inc., a medical device company, acquired by Stryker Corporation (NYSE: SYK) in November 2020. During a 12-year tenure with Wright, Mr. Treace served in a number of senior management roles including Vice President, Biologics and Extremities and Senior Director of Biologics Marketing. Before that, Mr. Treace held positions at Xomed Surgical Products, Inc., including as Director of Marketing and as Senior Product Manager, and with TreBay Medical Corp as Advertising & Marketing Director.  Mr. Treace also served on the board of directors of ENTrigue Surgical, acquired by Arthrocare Corporation in July 2013. Mr. Treace holds a B.S. in Finance from Seattle University.

M1228